Defining the right diluent for intravenous infusion of therapeutic antibodies
Sign Up to like & getrecommendations! Published in 2020 at "mAbs"
DOI: 10.1080/19420862.2019.1685814
Abstract: ABSTRACT Therapeutic monoclonal antibodies (mAbs) are commonly administered to patients through intravenous (IV) infusion, which involves diluting the medication into an infusion solution (e.g., saline and 5% dextrose). Using the wrong diluent can cause product… read more here.
Keywords: diluent intravenous; right diluent; infusion; infusion therapeutic ... See more keywords